Compare OSK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSK | ICLR |
|---|---|---|
| Founded | 1917 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 9.3B |
| IPO Year | 2009 | 2001 |
| Metric | OSK | ICLR |
|---|---|---|
| Price | $130.31 | $137.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $166.79 | ★ $178.62 |
| AVG Volume (30 Days) | 846.7K | ★ 981.3K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $7,705,500,000.00 | N/A |
| Revenue This Year | $5.94 | N/A |
| Revenue Next Year | $7.19 | N/A |
| P/E Ratio | $113.38 | ★ $12.91 |
| Revenue Growth | ★ 12.83 | N/A |
| 52 Week Low | $97.28 | $66.57 |
| 52 Week High | $180.49 | $211.00 |
| Indicator | OSK | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 70.29 |
| Support Level | $125.41 | $99.11 |
| Resistance Level | $138.99 | $193.87 |
| Average True Range (ATR) | 4.63 | 6.72 |
| MACD | 0.59 | 1.66 |
| Stochastic Oscillator | 55.12 | 91.36 |
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.